Abstract：
BACKGROUND:Standard chemotherapy in unresectable biliary tract carcinoma (BTC) patients is based on gemcitabine combined with platinum derivatives. However, primary or acquired resistance is inevitable and no second-line chemotherapy is demonstrated to be effective. Thus, there is an urgent need to identify new alternative (chemo)therapy approaches. METHODS:We evaluated the mechanism of action of ET-743 in preclinical models of BTC. Six BTC cell lines (TFK-1, EGI-1, TGBC1, WITT, KMCH, HuH28), two primary cell cultures derived from BTC patients, the EGI-1 and a new established BTC patient-derived xenografts, were used as preclinical models to investigate the anti-tumor activity of ET-743 in vitro and in vivo. Gene expression profiling was also analyzed upon ET-743 treatment in in vivo models. RESULTS:We found that ET-743 inhibited cell growth of BTC cell lines and primary cultures (IC50 ranging from 0.37 to 3.08 nM) preferentially inducing apoptosis and activation of the complex DNA damage-repair proteins (p-ATM, p-p53 and p-Histone H2A.x) in vitro. In EGI-1 and patient-derived xenografts, ET-743 induced tumor growth delay and reduction of vasculogenesis. In vivo ET-743 induced a deregulation of genes involved in cell adhesion, stress-related response, and in pathways involved in cholangiocarcinogenesis, such as the IL-6, Sonic Hedgehog and Wnt signaling pathways. CONCLUSIONS:These results suggest that ET-743 could represent an alternative chemotherapy for BTC treatment and encourage the development of clinical trials in BTC patients resistant to standard chemotherapy.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Peraldo-Neia C,Cavalloni G,Soster M,Gammaitoni L,Marchiò S,Sassi F,Trusolino L,Bertotti A,Medico E,Capussotti L,Aglietta M,Leone Fdoi
10.1186/1471-2407-14-918subject
Has Abstractpub_date
2014-12-05 00:00:00pages
918issn
1471-2407pii
1471-2407-14-918journal_volume
14pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:Previous studies have suggested that metformin may be useful for preventing and treating endometrial cancer (EC), while the results have been inconsistent. This systematic review and meta-analysis aimed to investigate the association between metformin use and risk and prognosis of patients with EC. METHODS:...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析,评审
doi：10.1186/s12885-018-4334-5
更新日期：2018-04-18 00:00:00
abstract：BACKGROUND:With the availability of effective anti-EGFR therapies for various solid malignancies, such as non-cell small lung cancer, colorectal cancer and squamous cell carcinoma of the head and neck, the knowledge of EGFR and K-RAS status becomes clinically important. The aim of this study was to analyse EGFR express...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/1471-2407-10-189
更新日期：2010-05-11 00:00:00
abstract：BACKGROUND:Less than 20% of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE SISter) study was designed to identify new breast cancer susceptibility genes in women attending cancer genetics clinics and with no BRCA1/...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-2028-9
更新日期：2016-01-12 00:00:00
abstract：BACKGROUND:Exercise has favorable effects on biomarkers associated with a lower risk of breast cancer, however it is unclear if higher doses of exercise provide additional effects. No clinical trial has systematically examined how different exercise volumes influence the mechanisms underlying breast cancer etiology. Th...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/1471-2407-14-919
更新日期：2014-12-06 00:00:00
abstract：BACKGROUND:The prognostic value of histone γ-H2AX and 53BP1 proteins to predict the radiotherapy (RT) outcome of patients with rectal carcinoma (RC) was evaluated in a prospective study. High expression of the constitutive histone γ-H2AX is indicative of defective DNA repair pathway and/or genomic instability, whereas ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1890-9
更新日期：2015-11-06 00:00:00
abstract：BACKGROUND:Phosphatase of regenerating liver-3 (PRL-3) has deserved attention as a crucial molecule in the multiple steps of metastasis. In the present study, we examined the mechanisms regulating PRL-3 expression, and assessed the clinical potential of PRL-3-targeted therapy in gastric cancer. METHODS:PRL-3 genomic a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-122
更新日期：2011-04-06 00:00:00
abstract：BACKGROUND:Selection of patients with local failure of nasopharyngeal carcinoma (NPC) for appropriate type of salvage treatment can be difficult due to the lack of data on comparative efficacy of different salvage treatments. The purpose of the present study was to validate a previously published prognostic scoring sys...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-131
更新日期：2009-04-29 00:00:00
abstract：BACKGROUND:Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a heterogenous group of tumors. Findings from the phase III NETTER-1 trial showed that treatment of unresectable/metastatic progressive gastrointestinal (GI) NETs with 177Lu-Dotatate resulted in a significant improvement in progression-free su...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07710-7
更新日期：2021-01-05 00:00:00
abstract：BACKGROUND:Long-term survival in numerous cancers often correlates with specific whole transcriptome profiles or the expression patterns of smaller numbers of transcripts. In some instances, these are better predictors of survival than are standard classification methods such as clinical stage or hormone receptor statu...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-06756-x
更新日期：2020-04-07 00:00:00
abstract：BACKGROUND:It has been proposed that mesenchymal stromal cells (MSCs) promote tumor progression by interacting with tumor cells and other stroma cells in the complex network of the tumor microenvironment. We characterized MSCs isolated and expanded from tumor tissues of pediatric patients diagnosed with neuroblastomas ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5082-2
更新日期：2018-11-27 00:00:00
abstract：BACKGROUND:Clinical interpretation of health related quality of life (HRQOL) scores is challenging. The purpose of this analysis was to interpret score changes and identify minimal clinically important differences (MCID) on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Cor...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-165
更新日期：2013-03-28 00:00:00
abstract：BACKGROUND:Reports on childhood cancer survivors estimated cumulative probability of developing secondary neoplasms vary from 3.3% to 25% at 25 years from diagnosis, and the risk of developing another cancer to several times greater than in the general population. METHODS:In our retrospective study, we have used the c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-27
更新日期：2007-02-02 00:00:00
abstract：BACKGROUND:Limited clinical data on real-world practice patterns are available for patients with metastatic/relapsed soft tissue sarcomas (STS). The primary objective of this study was to evaluate treatment patterns in patients with metastatic/relapsed STS following failure of prior chemotherapy by examining data colle...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1182-4
更新日期：2015-03-25 00:00:00
abstract：BACKGROUND:Breast metastasis from lung cancer has been reported, but not from SCLC that is transformed from lung adenocarcinoma during maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Transformation to small cell lung cancer(SCLC), although uncommonly seen, has been asso...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2623-4
更新日期：2016-08-03 00:00:00
abstract：BACKGROUND:The phase 3 MPACT trial in patients with metastatic pancreatic cancer demonstrated superior efficacy of nab-paclitaxel (nab-P) + gemcitabine (Gem) vs Gem monotherapy for all endpoints examined including overall survival, the primary endpoint. In the MPACT trial, patients were treated until progressive diseas...
journal_title：BMC cancer
pub_type： 杂志文章,随机对照试验
doi：10.1186/s12885-016-2798-8
更新日期：2016-10-21 00:00:00
abstract：BACKGROUND:Based on the mechanism of action, combining somatostatin analogues (SSAs) with mTOR inhibitors or antiangiogenic agents may provide synergistic effects for the treatment of patients with neuroendocrine tumours (NETs). Herein, we investigate the use of these treatment combinations in clinical practice. METHO...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1512-6
更新日期：2015-07-04 00:00:00
abstract：BACKGROUND:Cytokines are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play key role in tumor dissemination and are an independent survival predictor in breast cancer patients. The aim of this study was to assess correlation between CTCs and plasma cytokines in primary breast cancer (PBC) p...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2143-2
更新日期：2016-02-19 00:00:00
abstract：BACKGROUND:The care itinerary for cancer involves difficulties that occur in several different areas, whether in the diagnostic procedures, in surgery, or in adjuvant treatment. The aim of this work was to obtain a valid instrument measuring satisfaction among patients with breast cancer and exploring their care itiner...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-129
更新日期：2007-07-16 00:00:00
abstract：BACKGROUND:Two functional single nucleotide polymorphisms (SNPs) in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, C677T and A1298C, lead to decreased enzyme activity and affect chemosensitivity of tumor cells. We investigated whether these MTHFR SNPs were associated with breast cancer survival in African-A...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-257
更新日期：2006-10-27 00:00:00
abstract：BACKGROUND:Patients with metastatic renal carcinoma frequently have pre-existing renal impairment and not infrequently develop worsening renal function as a complication of their treatment. The presence of pancreatic metastases in patients with metastatic renal carcinoma, often confers a more favourable prognosis and a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6215-y
更新日期：2019-10-17 00:00:00
abstract：BACKGROUND:About 5-10% of breast cancer is due to inherited disease predisposition. Many previously identified susceptibility factors are involved in the maintenance of genomic integrity. AATF plays an important role in the regulation of gene transcription and cell proliferation. It induces apoptosis by associating wit...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-457
更新日期：2009-12-21 00:00:00
abstract：BACKGROUND:The five-year survival rates for head and neck squamous cell carcinoma (HNSCC) patients are less than 50%, and the prognosis has not improved, despite advancements in standard multi-modality therapies. Hence major emphasis is being laid on identification of novel molecular targets and development of multi-ta...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-655
更新日期：2010-11-30 00:00:00
abstract：BACKGROUND:We aimed to evaluate the prognostic value of quality of life (QOL) for predicting survival among disease-free survivors of surgically-treated lung cancer after the completion of cancer treatment. METHODS:We administered the European Organization for Research and Treatment of Cancer Quality of Life Questionn...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2504-x
更新日期：2016-07-20 00:00:00
abstract：BACKGROUND:Amyloid-β precursor protein (APP) is a highly conserved single transmembrane protein that has been linked to Alzheimer disease. Recently, the increased expression of APP in multiple types of cancers has been reported where it has significant correlation with the cancer cell proliferation. However, the functi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-928
更新日期：2014-12-10 00:00:00
abstract：BACKGROUND:The primary aim of treatment of a patient who has developed metastatic disease is palliation. The objectives of the current study are to describe and quantify the clinical management of women with metastatic breast cancer from the diagnosis of metastatic disease until death and to analyze differences between...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-179
更新日期：2006-07-06 00:00:00
abstract：BACKGROUND:Lymphotoxin-alpha (LTA) is a pro-inflammatory cytokine with anti-tumor activity. The objective of this study was to determine whether LTA polymorphisms influence the presence of cancer. METHODS:LTA polymorphisms C804A (rs1041981, T60N) and T495C (rs2229094, C13R) were determined in 1,536 consecutive autopsy...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-235
更新日期：2008-08-13 00:00:00
abstract：BACKGROUND:Given their frequency of occurrence in the United States, cancer and heart disease often coexist. For patients requiring open-heart surgery, this raises concern that the use of cardiopulmonary bypass (CPB) may cause a transient immunosuppression with the potential to promote the spread and growth of coexisti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-519
更新日期：2013-11-03 00:00:00
abstract：BACKGROUND:Merkel cell carcinoma (MCC) is a rare cutaneous neoplasm with increasing incidence, aggressive behavior and poor prognosis. Somatostatin receptors (SSTR) are expressed in MCC and represent a potential target for both imaging and treatment. METHODS:To non-invasively assess SSTR expression in MCC using PET an...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-268
更新日期：2014-04-17 00:00:00
abstract：BACKGROUND:For decades, planar bone scintigraphy has been the standard practice for detection of bone metastases in prostate cancer and has been endorsed by recent oncology/urology guidelines. It is a sensitive method with modest specificity. (18)F-fluoride positron emission tomography/computed tomography has shown imp...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/s12885-016-2047-1
更新日期：2016-01-11 00:00:00
abstract：BACKGROUND:The majority of patients undergoing hepatectomy for hepatocellular carcinoma (HCC) suffer from underlying liver disease and are exposed to the risk of postoperative ascites, which is favored by an imbalance between portal venous inflow and a diminished hepatic volume. Finding a reversible, non-invasive metho...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/s12885-018-4667-0
更新日期：2018-08-23 00:00:00
